HOME >> BIOLOGY >> NEWS
Major grants support immunology, transplant and diabetes research at the University of Chicago

At a campus press briefing on October 6, the Juvenile Diabetes Foundation (JDF) and the National Institute of Allergy and Infectious Diseases (NIAID) announced two major, closely related, multi-year grants to research teams headquartered at the University of Chicago.

The JDF has awarded $7.5 million over a five-year period to establish the JDF Center for Islet Transplantation at the University of Chicago/University of Minnesota. The NIAID has launched a seven-year, $144-million initiative, involving nearly 40 research institutions to be known as the Collaborative Network for Clinical Research on Immune Tolerance.

Both projects will be directed by Jeffrey Bluestone, Ph.D., the Daniel K. Ludwig Professor of Pathology, Chairman of the Committee on Immunology and Director of the Ben May Institute for Cancer Research at the University of Chicago.

The JDF Center for Islet Transplantation, made possible by generous support from the McDonough Family Foundation in Chicago, will advance the use of transplants of insulin-producing pancreatic islets as a cure for diabetes. It will focus on finding new ways to prevent the body from rejecting islet transplants without causing dangerous side effects.

The Collaborative Network will concentrate on developing and testing new ways to induce immune tolerance by selectively modulating the immune system to inhibit harmful responses yet keep protective ones intact. This strategy promises to improve the success of transplants as well as treatments for autoimmune diseases such as type 1 diabetes, lupus and rheumatoid arthritis, which destroy the body's own cells.

"These are two vitally important, far-reaching and daring projects and we are pleased and honored that both will be based at the University of Chicago," said Glenn Steele, M.D., Ph.D., Dean of the Division of the Bio
'"/>

Contact: John Easton
jeaston@mcis.bsd.uchicago.edu
773-702-6241
University of Chicago Medical Center
6-Oct-1999


Page: 1 2 3 4

Related biology news :

1. Major scientific discovery in cancer research to be honored
2. Major U.S. environmental policy bears scrutiny in midlife
3. Major boost for European zebrafish research
4. Major mutations, not many small changes, might lead way to new species
5. Major new finding on genetics of Parkinsons disease zeroes in on activity of alpha synuclein
6. Major stress during pregnancy linked to autism
7. Major fossil find reveals Asian origins of salamanders
8. Major unique new study shows infrequent inspections lead to greater stream pollution
9. Major new initiative to resolve structure of protein families
10. Major air pollution study launched
11. Major grant to aid McGill University professors efforts to improve school science teaching

Post Your Comments:
(Date:10/15/2014)... from strains of influenza virus increases with the latest ... complacent that the most substantial threats have been identified, ... arise when a new virus strain – against which ... in the human population. There have been five such ... which – the 1918 Spanish Flu – cost 50 ...
(Date:10/15/2014)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... growing mobile commerce market releases photos and video of the recent ... October 13 th . Gino Pereira , ... angel investor Mr. Chad A. Verdi rang the bell.  ... his investors and employees "for their work and dedication in bringing ...
(Date:10/14/2014)... of years since T. rex took its ... scientists is breathing life back into dinosaurs using high-powered ... research has important implications for how dinosaurs used their ... sense of smell and cool their brains. , ... student Jason Bourke, lead author of the new study ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
(Date:10/25/2014)... (PRWEB) October 24, 2014 The ... the nation’s leading nonprofit authority on the use ... information exchange, announces its appointment of four new ... The workgroup leaders include:, ,     Peter ...     Erik Pupo, Specialist Leader, Deloitte Consulting LLP ...
(Date:10/25/2014)... (PRWEB) October 24, 2014 SonaCare ... focused ultrasound (HIFU) technology, announced that its Board ... as Chief Executive Officer, President and member of ... Dr. Carol will take-on expanded responsibilities within the ... as well as overseeing commercialization, manufacturing and finance. ...
(Date:10/25/2014)... , October 24, 2014 ... clinical-stage pharmaceutical company focused on the development of oral ... Nadav Kidron will present at FireRock Capital,s ... Capital,s Annual Micro-Cap Conference ,Date: Tuesday, October 28, 2014 ... New York City , ...
(Date:10/25/2014)... -- Investor-Edge has initiated coverage on the ... Vertex Pharmaceuticals Inc. (NASDAQ: VRTX ), Alexion ... Inc. (NASDAQ: PPHM ), and StemCells Inc. ... be accessed at: http://investor-edge.com/register . The ... a positive note as the Dow Jones Industrial Average ...
Breaking Biology Technology:WEDI Appoints Four New Security and Privacy Workgroup Co-chairs 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 3Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5
Cached News: